Have a personal or library account? Click to login
A Long-Forgotten Tale: The Management of Cardiogenic Shock in Acute Myocardial Infarction Cover

A Long-Forgotten Tale: The Management of Cardiogenic Shock in Acute Myocardial Infarction

Open Access
|Jan 2019

References

  1. 1. Dregoesc MI, Iancu AC, Cucu T, Marc MC. Chasing a Ghost: The Index of Microvascular Resistance. J Am Coll Cardiol Intv. 2017;10:1066-1067. doi: 10.1016/j.jcin.2017.03.008.
  2. 2. Sleeper LA, Ramanathan K, Picard MH, et al. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2005;46:266-273. doi: 10.1016/j.jacc.2005.01.061.
  3. 3. Tschöpe C, Van Linthout S, Klein O, et al. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BIPELLA, and PROPELLA Concepts. J Cardiovasc Transl Res. 2018; doi: 10.1007/s12265-018-9820-2. [Epub ahead of print]
  4. 4. Van Diepen S, Katz JN, Albert NM, et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Circulation. 2017;136:e232-e268. doi: 10.1161/CIR.0000000000000525.
  5. 5. Chen HY, Gore JM, Lapane KL, et al. A 35-Year Perspective (1975 to 2009) into the Long-Term Prognosis and Hospital Management of Patients Discharged from the Hospital After a First Acute Myocardial Infarction. Am J Cardiol. 2015;116:24-29. doi: 10.1016/j.amjcard.2015.03.035.
  6. 6. Shah M, Patil S, Patel B, et al. Causes and Predictors of 30- Day Readmission in Patients With Acute Myocardial Infarction and Cardiogenic Shock. Circ Heart Fail. 2018;11:e004310. doi: 10.1161/CIRCHEARTFAILURE.117.004310.
  7. 7. Kolte D, Khera S, Aronow WS, et al. Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction in the United States. J Am Heart Assoc. 2014;3:e000590. doi: 10.1161/JAHA.113.000590.
  8. 8. Haller PM, Jäger B, Farhan S, et al. Impact of age on shortand long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network. Wien Klin Wochenschr. 2018;130:172-181. doi: 10.1007/s00508-017-1250-7.
  9. 9. Dharma S, Andriantoro H, Purnawan I, et al. Characteristics, treatment and in-hospital outcomes of patients with STEMI in a metropolitan area of a developing country: an initial report of the extended Jakarta Acute Coronary Syndrome registry. BMJ Open. 2016;6:e012193. doi: 10.1136/bmjopen-2016-012193.
  10. 10. Sousa-Uva M, Neumann FJ, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019;55:4-90. doi: 10.1093/ejcts/ezy289.
  11. 11. Rab T, Ratanapo S, Kern KB, et al. Cardiac Shock Care Centers. J Am Coll Cardiol. 2018;72:1972-1980. doi: 10.1016/j.jacc.2018.07.074.
  12. 12. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2129-2200. doi: 10.1093/eurheartj/ehw128.
  13. 13. Chakravarthy M, Tsukashita M, Murali S. A Targeted Management Approach to Cardiogenic Shock. Crit Care Clin. 2018;34:423-437. doi: 10.1016/j.ccc.2018.03.009.
  14. 14. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625-663. doi: 10.1056/NEJM199908263410901.
  15. 15. Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177. doi: 10.1093/eurheartj/ehx393.
  16. 16. Marc MC, Iancu AC, Ober CD, et al. Pre-revascularization coronary wedge pressure as marker of adverse long-term left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. Sci Rep. 2018;8:1897. doi: 10.1038/s41598-018-20276-6.
  17. 17. Kramer MC, Van Der Wal AC, Koch KT, et al. Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation. 2008;118:1810-1816. doi: 10.1161/CIRCULATIONAHA.108.780734.
  18. 18. Wayangankar SA, Bangalore S, McCoy LA, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. J Am Coll Cardiol Intv. 2016;9:341-351. doi: 10.1016/j.jcin.2015.10.039.
  19. 19. Taylor R. White coat tales: Medicine’s heroes, heritage and misadventures. New York: Springer; 2008.10.1007/978-0-387-73080-6
  20. 20. Kapur NK, Davila CD, Jumean MF. Integrating interventional cardiology and heart failure management for cardiogenic shock. Inter Cardiol Clin. 2017;6:481-485. doi: 10.1016/j.iccl.2017.03.014.
  21. 21. Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377:2419-2432. doi: 10.1056/NEJMoa1710261.
  22. 22. Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an openlabel, randomised controlled trial. Lancet 2015;386:665-671.10.1016/S0140-6736(15)60648-1
  23. 23. Montalescot G, Andersen HR, Antoniucci D, et al. Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart. 2004;90:e37.10.1136/hrt.2003.016014
  24. 24. Masci PG, Bogaert J. Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI. Cardiovasc Diagn Ther. 2012;2:113-127. doi: 10.3978/j.issn.2223-3652.2012.04.06.
  25. 25. Bonow RO, Maurer G, Lee KL, et al. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. N Engl J Med. 2011;364:1617-1625. doi: 10.1056/NEJMoa1100358.
  26. 26. Bonow RO, Castelvecchio S, Panza JA, et al. Ischemic Left Ventricular Dysfunction: Severity of Remodeling, Myocardial Viability and Survival After Surgical Revascularization. JACC Cardiovasc Imaging. 2015;8:1121-1129. doi: 10.1016/j.jcmg.2015.03.013.
  27. 27. Ternus BW, Jentzer JC, El Sabbagh A, et al. Percutaneous Mechanical Circulatory Support for Cardiac Disease: Temporal Trends in Use and Complications Between 2009 and 2015. J Invasive Cardiol. 2017;29:309-313.
  28. 28. Saad M, Fuernau G, Desch S, et al. Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial. EuroIntervention. 2018;14:e306-e313. doi: 10.4244/EIJ-D-17-00451.
  29. 29. Sodhi N, Lasala JM. Mechanical Circulatory Support in Acute Decompensated Heart Failure and Shock. Interv Cardiol Clin. 2017;6:387-405. doi: 10.1016/j.iccl.2017.03.008.
  30. 30. Thiele H, Jobs A, Ouweneel DM, et al. Percutaneous shortterm active mechanical support devices in cardiogenic shock: A systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 2017;38:3523-3531. doi: 10.1093/eurheartj/ehx363.
  31. 31. Imamura T, Juricek C, Nguyen A, et al. Predictors of Hemodynamic Improvement and Stabilization Following Intraaortic Balloon Pump Implantation in Patients With Advanced Heart Failure. J Invasive Cardiol. 2018;30:56-61.
  32. 32. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N Engl J Med. 2012;367:1287-1296. doi: 10.1056/NEJMoa1208410.
  33. 33. Ouweneel DM, Schotborgh JV, Limpens J, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 2016;42:1922-1934. doi: 10.1007/s00134-016-4536-8.
  34. 34. Flaherty MP, Khan AR, O'Neill WW. Early Initiation of Impella in Acute Myocardial Infarction Complicated by Cardiogenic Shock Improves Survival: A Meta-Analysis. JACC Cardiovasc Interv. 2017;10:1805-1806. doi: 10.1016/j.jcin.2017.06.027.
  35. 35. Lauten A, Engstrom AE, Jung C, et al. Percutaneous leftventricular support with the Impella-2.5-assist device in acute cardiogenic shock: Results of the Impella EUROSHOCKregistry. Circ Heart Fail 2013;6:23-30. doi: 10.1161/ CIRCHEARTFAILURE.112.967224.
  36. 36. Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, et al. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117:1622-1628. doi: 10.1016/j. amjcard.2016.02.038.
  37. 37. Post PN, Kuijpers M, Ebels T, et al. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. Eur Heart J. 2010;31:1985-1992. doi: 10.1093/eurheartj/ehq151.
  38. 38. Shaefi S, O’Gara B, Kociol RD, et al. Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc. 2015;4:e001462. doi: 10.1161/JAHA.114.001462.
  39. 39. Na SJ, Park TK, Lee GY, et al. Impact of a cardiac intensivist on mortality in patients with cardiogenic shock. Int J Cardiol. 2017;244:220-225. doi: 10.1016/j.ijcard.2017.06.082.
  40. 40. Na SJ, Chung CR, Jeon K, et al. Association between presence of a cardiac intensivist and mortality in an adult cardiac care unit. J Am Coll Cardiol. 2016;68:2637-2648. doi: 10.1016/j.jacc.2016.09.947.
  41. 41. Stolker JM, Badawi O, Spertus JA, et al. Intensive Care Units With Low Versus High Volume of Myocardial Infarction: Clinical Outcomes, Resource Utilization, and Quality Metrics. J Am Heart Assoc. 2015;4:e001225. doi: 10.1161/JAHA.114.001225.
  42. 42. Kontos MC, Wang TY, Chen AY, et al. The effect of high-risk ST elevation myocardial infarction transfer patients on riskadjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline program. Am Heart J. 2016;180:74-81. doi: 10.1016/j.ahj.2016.07.010.
  43. 43. Basir MB, Schreiber TL, Grines CL, et al. Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. Am J Cardiol. 2017;119:845-851. doi: 10.1016/j.amjcard.2016.11.037.
  44. 44. Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: Results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39:1065-1074. doi: 10.1093/eurheartj/ehy004.
  45. 45. Benedek I, Gyongyosi M, Benedek T. A prospective regional registry of ST-elevation myocardial infarction in central Romania. Impact of the Stent for Life initiative recommendations on patient outcomes. Am Heart J. 2013;166:457-465. doi: 10.1016/j.ahj.2013.03.033.
  46. 46. Terkelsen CJ, Sorensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304:763-771. doi: 10.1001/jama.2010.1139.
  47. 47. Fordyce C, Al-Khalidi H, Jollis J, et al. Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction Networks. Circ Cardiovasc Interv. 2017;pii:e004061. doi: 10.1161/CIRCINTERVENTIONS.
  48. 48. Stowens JC, Sonnad SS, Rosenbaum RA. Using EMS dispatch to trigger STEMI alerts decreases door-to-balloon times. West J Emerg Med. 2015;16:472-480. doi: 10.5811/westjem.2015.4.24248.
  49. 49. Nallamothu BK, Normand SL, Wang Y, et al. Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet. 2015;385:1114-1122. http://dx.doi.org/10.1016/S0140-6736(14)61932-2.10.1016/S0140-6736(14)61932-2
  50. 50. Welsh RC, Chang W, Goldstein P, et al. Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial. Heart. 2005;91:1400-1406. doi: 10.1136/hrt.2004.054510.
  51. 51. Henry TD, Sharkey SW, Burke MN, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116:721-728. doi: 10.1161/CIRCULATIONAHA.107.694141.
  52. 52. García-García C, Ribas N, Recasens LL, et al. In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. “Head to head” analysis: invasive reperfusion vs. optimal medical therapy. BMC Cardiovasc Disord. 2017;17:139. doi: 10.1186/s12872-017-0574-6.
  53. 53. Regueiro A, Fernández-Rodríguez D, et al. False Positive STEMI Activations in a Regional Network: Comprehensive Analysis and Clinical Impact. Results From the Catalonian Codi Infart Network. Rev Esp Cardiol (Engl Ed). 2017;pii:S1885-5857(17)30305-5. doi: 10.1016/j.rec.2017.06.001.
  54. 54. Kontos MC, Wang TY, Chen AY, et al. The effect of high-risk ST elevation myocardial infarction transfer patients on risk adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline program. Am Heart J. 2016;180:74-81. doi: 10.1016/j.ahj.2016.07.010.
  55. 55. Park JJ, Yoon CH, Suh JW, et al. Reduction of Ischemic Time for Transferred STEMI Patients Using a Smartphone Social Network System. J Am Coll Cardiol. 2016;68:1490-1492. doi: 10.1016/j.jacc.2016.07.733.
  56. 56. Harjola VP, Lassus J, Sionis A, et al. CardShock Study Investigators; GREAT Network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17:984. doi: 10.1002/ejhf.260.
  57. 57. Morrison LJ, Neumar RW, Zimmerman JL, et al. Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: A consensus statement from the American Heart Association. Circulation. 2013;127:1538-1563. doi: 10.1161/CIR.0b013e31828b2770.
  58. 58. Chan PS, Jain R, Nallmothu BK, et al. Rapid response teams: A systematic review and meta-analysis. Arch Intern Med. 2010;170:18-26. doi: 10.1001/archinternmed.2009.424.
  59. 59. Ghosh R, Pepe P. The critical care cascade: A systems approach. Curr Opin Crit Care. 2009;15:279-283. doi: 10.1097/MCC.0b013e32832faef2.
  60. 60. Jaroszewski DE, Kleisli T, Staley L, et al. A traveling team concept to expedite the transfer and management of unstable patients in cardiopulmonary shock. J Heart Lung Transplant. 2011;30:618-623. doi: 10.1016/j.healun.2010.11.018.
  61. 61. Bonnefoy-Cudraz E, Bueno H, Casella G, et al. Acute Cardiovascular Care association Position Paper on Intensive Cardiovascular Care Units: An Update on their definition, structure, organization and function. Eur Heart J Acute Cardiovascular Care. 2018;7:80-95. doi: 10.1177/2048872617724269.
  62. 62. Avalli L, Maggioni E, Formica F, et al. Favourable survival of inhospital compared to out-of-hospital refractory cardiac arrest patients treated with extracorporeal membrane oxygenation: an Italian tertiary care centre experience. Resuscitation. 2012;83:579-583. doi: 10.1016/j.resuscitation.2011.10.013.
  63. 63. Mojoli F, Venti A, Pellegrini C, et al. Hospital survival and long term quality of life after emergency institution of venoarterial ECMO for refractory circulatory collapse. Minerva Anestesiol. 2013;79:1147-1155.
  64. 64. Kagawa E. Extracorporeal cardiopulmonary resuscitation for adult cardiac arrest patients. World J Crit Care Med. 2012;1:46-49. doi: 10.5492/wjccm.v1.i2.46.
  65. 65. Kagawa E, Inoue I, Kawagoe T, et al. Assessment of outcomes and differences between in- and out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal life support. Resuscitation. 2010;81:968-973. doi: 10.1016/j.resuscitation.2010.03.037.
  66. 66. Teschendorf P, Bernhard M. A bridge to life: ECPR who, when, where and why? Resuscitation. 2014;85:709-710. doi: 10.1016/j.resuscitation.2014.03.315.
  67. 67. Biderman P, Kagan I, Jakobishvili Z, Fainblut M, Lishetzinsky Y, Cohen J. Extracorporeal Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest. Isr Med Assoc J. 2016;18:61-62.
  68. 68. Choi DS, Kim T, Ro YS, et al. Extracorporeal life support and survival after out-of-hospital cardiac arrest in a nationwide registry: A propensity score-matched analysis. Resuscitation. 2016;99:26-32. doi: 10.1016/j.resuscitation.2015.11.013.
  69. 69. Stub D, Bernard S, Pellegrino V, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation. 2015;86:88-94. doi: 10.1016/j.resuscitation.2014.09.010.
  70. 70. Belohlavek J, Kucera K, Jarkovsky J, et al. Hyperinvasive approach to out-of hospital cardiac arrest using mechanical chest compression device, prehospital intraarrest cooling, extracorporeal life support and early invasive assessment compared to standard of care. A randomized parallel groups comparative study proposal. “Prague OHCA study”. J Transl Med. 2012;10:163. doi: 10.1186/1479-5876-10-163.
  71. 71. Beurtheret S, Mordant P, Paoletti X, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J. 2013;34:112-120. doi: 10.1093/eurheartj/ehs081.
  72. 72. Hwang WS, Park JS, Kim SJ, Hong YS, Moon SW, Lee SW. A system-wide approach from the community to the hospital for improving neurologic outcomes in out-of-hospital cardiac arrest patients. Eur J Emerg Med. 2017;24:87-95. doi: 10.1097/MEJ.0000000000000313.
  73. 73. Avalli L, Mauri T, Citerio G, et al. New treatment bundles improve survival in out-of-hospital cardiac arrest patients: a historical comparison. Resuscitation. 2014;85:1240-1244. doi: 10.1016/j.resuscitation.2014.06.014.
  74. 74. Grunau B, Reynolds J, Scheuermeyer F, et al. Relationship between Time-to-ROSC and Survival in Out-of-hospital Cardiac Arrest ECPR Candidates: When is the Best Time to Consider Transport to Hospital? Prehosp Emerg Care. 2016;20:615-622. doi: 10.3109/10903127.2016.1149652.
  75. 75. Leick J, Liebetrau C, Szardien S, et al. Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest. Clin Res Cardiol. 2013;102:661-669. doi: 10.1007/s00392-013-0580-3.
  76. 76. Scholz KH, von Knobelsdorff G, Ahlersmann D, et al. Optimizing systems of care for patients with acute myocardial infarction. STEMI networks, telemetry ECG, and standardized quality improvement with systematic data feedback. Herz. 2008;33:102-109. doi: 10.1007/s00059-008-3120-6.
  77. 77. Claeys MJ, Sinnaeve PR, Convens C, et al. STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme. Eur Heart J Acute Cardiovasc Care. 2012;1:40-47. doi: 10.1177/2048872612441579.
  78. 78. Rokos I, Henry T, Weittenhiller B, et al. Mission: Lifeline STEMI Networks Geospatial Information Systems (GIS) Maps. Crit Pathw Cardiol. 2013;13:43-44. doi: 10.1097/HPC.0b013e31828cfe1b.
  79. 79. Bagai A, Al-Khalidi HR, Sherwood M, et al. Regional systems of care demonstration project: Mission: Lifeline STEMI Systems Accelerator: Design and methodology. Am Heart J. 2014;167:15-21. doi: 10.1016/j.ahj.2013.10.005.
  80. 80. Wong GC, van Diepen S, Ainsworth C, et al. Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on the Optimal Care of the Postarrest Patient. Can J Cardiol. 2017;33:1-16. doi: 10.1016/j.cjca.2016.10.021.
  81. 81. Beurtheret S, Mordant P, Paoletti X, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J. 2013;34:112-120. doi: 10.1093/eurheartj/ehs081.
  82. 82. Takayama H, Truby L, Koekort M, et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant. 2013;32:106-111. doi: 10.1016/j.healun.2012.10.005.
  83. 83. Doll JA, Ohman EM, Patel MR, et al. A team-based approach to patients in cardiogenic shock. Catheter Cardiovasc Interv. 2016;88:424-433. doi: 10.1002/ccd.26297.
DOI: https://doi.org/10.2478/jce-2018-0023 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 170 - 177
Submitted on: Oct 16, 2018
|
Accepted on: Nov 23, 2018
|
Published on: Jan 18, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Adrian Corneliu Iancu, Mihaela Ioana Dregoesc, Aurelia Solomoneanu, Theodora Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.